A new independent academic study examining a form of blood cancer among those who served at Malmstrom Air Force Base, Montana ...

The ongoing phase 2b SunRISe-1 study is assessing TAR-200 intravesical gemcitabine delivery in patients with BCG-unresponsive high-risk NMIBC.